Skip to main content Accessibility help
×
Home

Behavioral correlates of GABAergic disruption in Alzheimer's disease

  • Krista L. Lanctôt (a1) (a2) (a3) (a4), Nathan Herrmann (a1) (a2) (a4) (a5), Lana Rothenburg (a1) (a2) and Goran Eryavec (a4) (a5) (a6)

Abstract

Background: Losses of γ-aminobutyric acid (GABA) have been variably demonstrated in Alzheimer's disease (AD) and may be related to the presence of behavioral and psychological symptoms of dementia (BPSD) in AD. Our objective was to assess the relationship between plasma GABA (pGABA) levels and specific BPSD in patients with severe AD.

Methods: pGABA levels and BPSD were measured in 14 institutionalized AD patients (8M/6F, mean age ± S.D. = 85.6 ± 4.5 years) with severe cognitive impairment (Mini-mental State Examination score = 4.5 ± 4.6) and prominent behavioral disturbances (Neuropsychiatric Inventory (NPI) score = 33.4 ± 23.6).

Results: pGABA was positively correlated with depression and apathy scores on the NPI and negatively correlated with age. Apathy and age were independent predictors of pGABA levels.

Conclusions: The final stages of AD are associated with GABAergic changes, which may contribute to depression and apathy in AD.

Copyright

Corresponding author

Correspondence should be addressed to: Dr. Krista L. Lanctôt, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Rm. FG05, Toronto, ON M4N 3M5, Canada. Phone: +1 416 480 6100 x2241; Fax: +1 416 480 6022. Email: Krista.Lanctot@sunnybrook.ca.

Keywords

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed